Back

Abivax gets positive pre-NDA FDA feedback for Obefazimod

Verifying
  • Abivax received positive pre-NDA feedback for its drug Obefazimod from the U.S. FDA.
  • Wedbush recently cut its Obefazimod price target to $118.
  • Analysts maintain a Moderate Buy consensus with an average target of $....
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.